ECO Animal Health Group plc (EAH.L)
LSE · GBp · Healthcare · Drug Manufacturers - Specialty & Generic
£95.00 (-0.52%) as of
Key statistics
- Market cap
- 63.39M
- P/E (TTM)
- 31.67
- Forward P/E
- 19.96
- EPS (TTM)
- 0.03
- Dividend yield
- 0.00%
- 52-week range
- 80.01 – 116.90
- Beta
- -0.01
- Revenue (TTM)
- 87.53M
- Profit margin
- 2.50%
- Analyst target
- £202.00
- Volume
- 3.57k
About ECO Animal Health Group plc
ECO Animal Health Group plc, together with its subsidiaries, manufactured and supply animal health products internationally. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers Ecomectin to treat parasites in cattle, sheep, and pigs; and ECOVAXXIN MS, a mycoplasma solution. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- London, United Kingdom
- Employees
- 213
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.